Market research
8C4.F CYBERDYNE Inc
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 261M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.84
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- JP3311530004
- Market cap
- 261M
- P/E ratio
- 0.0
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.84
About
About CYBERDYNE Inc
CYBERDYNE Inc. researches, develops, produces, sell, leases, and maintains robotic equipment and systems for medical and welfare in Japan, the United States, Europe, the Middle East, Africa, and the Asia Pacific countries. The company offers Hybrid Assistive Limb (HAL) for medical use in lower limb and single joint type; non-medical HAL for lower limb, single joint type, and lumbar type; HAL peripherals; cleaning robots; transportation robots for various transportation tasks in factories, offices, and other indoor environments; Acoustic X, a high-speed light pulse LED array light source that enables real time photoacoustic imaging; and CYIN for living support, which is an interface that uses biological information that can be controlled voluntarily outside of muscle activities. It also provides Cybernics Treatment, a treatment that uses HAL to enhance and regenerate the function of the wearer for spinal cord injury, stroke, neuromuscular diseases, etc.; Neuro HALFIT for enhancement of brain-nerve-musculoskeltal system; MTX Neuro HAL Plus to enhance the performance of the athletes' brain-nerve functions; and Neuro HALFIT at home for enhancement of physical functions. In addition, the company provides rescue support in disaster sites, and heavy labor support for factories and plants, as well as engages in the entertainment business. CYBERDYNE Inc. was incorporated in 2004 and is headquartered in Tsukuba, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 8C4.F discussion.
5 years, 5 months ago
CYBERDYNE Inc is currently in a long term downtrend where the price is trading 31.2% below its 200 day moving average.
From a valuation standpoint, the stock is 94.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 77.2.
CYBERDYNE Inc's total revenue rose by 2.5% to $453M since the same quarter in the previous year.
Its net income has dropped by 186.9% to $-86M since the same quarter in the previous year.
Finally, its free cash flow fell by 110.4% to $-423M since the same quarter in the previous year.
Based on the above factors, CYBERDYNE Inc gets an overall score of 2/5.